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DOSE RESPONSE RELATIONSHIP BETWEEN WEIGHT LOSS AND
IMPROVEMENT IN QUALITY OF LIFE IN PERSONS WITH
SYMPTOMATIC KNEE OSTEOARTHRITIS
J. Makovey y, L. Lawler z, K.L. Bennell x, D.J. Hunter y,k. y Inst. of Bone and
Joint Res., Kolling Inst., Univ. of Sydney, Sydney, Australia; z Prima Hlth.
Solutions, Sydney, Australia; xCtr. for Hlth., Exercise and Sports Med.,
Dept. of Physiotherapy, Univ. of Melbourne, Melbourne, Australia;
kRheumatology Dept., Royal North Shore Hosp., Sydney, Australia
Purpose: It has been established that weight reduction has the ability to
decrease pain and disability in knee osteoarthritis (OA) in a dose-
response manner. A greater weight loss causes incremental improve-
ment in disease speciﬁc symptoms and function. Whether this
improvement leads to commensurate improvements in quality of life
remains unknown. This study examined whether there is a dose-
response relationship between incremental weight loss and non-dis-
ease speciﬁc quality of life measures in knee OA sufferers.
Methods: Consecutive participants with knee OA enrolled in a weight
loss program, “Healthy weight for life”, as part of the full “Integrated
Osteoarthritis Management TM Program” were selected. This program
is a structured remotely delivered 18 week knee and hip arthritis dis-
ease management program that systematically integrates intensiveTable 1. Dose-response of weight change with the change in SF-12 measures
Baseline
measures
Mean (SD)
Weight Loss (%) Categories
All (N¼1811)
Mean D (SD)
2.5 (N¼130)
Mean D (SD)
2.5-5% (N¼301)
Mean D (SD)
5-7.5% (N¼462)
Mean D (SD)
7.5-10% (N¼395)
Mean D (SD)
10% (N¼532)
Mean D (SD)
Signiﬁcance
linearity
Weight (kg) 95.3 (17.5) -7.63 (4.22) -1.13 (1.12) -3.73 (0.96) -5.89 (1.28) -8.25 (1.67) -12.40 (3.44) 0.000
Changes in SF-12 Composite measures
Physical Health Composite Score (PCS) 33.4 (7.2) 6.65 (8.24) 3.16 (8.24) 4.07 (8.02) 6.73 (7.83) 6.65 (8.17) 8.60 (8.18) 0.000
Mental Health Composite Score (MCS) 43.2 (10.0) 5.25 (9.73) 3.58 (10.49) 2.38 (9.86) 5.11 (9.63) 5.89 (9.31) 6.66 (9.56) 0.000
Changes in SF-12 subdomains
Physical Functioning 3.5 (1.1) 0.53 (1.17) 0.23 (1.14) 0.27 (1.11) 0.50 (1.09) 0.50 (1.24) 0.76 (1.18) 0.000
Role Functioning (Physical) 2.4 (0.7) 0.76 (1.01) 0.43 (1.06) 0.49 (1.02) 0.72 (0.98) 0.81 (0.99) 0.95 (1.01) 0.000
Bodily Pain 2.8 (0.9) -0.42 (1.64) -0.57 (1.63) -0.11 (1.68) -0.38 (1.67) -0.35 (1.61) -0.62 (1.58) 0.000
General Health 3.3 (0.9) 0.46 (0.87) 0.21 (0.86) 0.21 (0.85) 0.47 (0.87) 0.45 (0.90) 0.63 (0.83) 0.000
Vitality 2.1 (1.1) 0.80 (1.12) 0.48 (1.18) 0.49 (1.20) 0.80 (1.13) 0.82 (1.07) 1.02 (1.06) 0.000
Social Functioning 4.7 (1.3) 0.53 (1.23) 0.4 (1.27) 0.23 (1.10) 0.50 (1.22) 0.62 (1.20) 0.66 (1.27) 0.000
Role Functioning (Emotional) 3.3 (0.9) 0.24 (0.96) 0.03 (1.08) 0.10 (1.01) 0.21 (0.95) 0.33 (0.92) 0.33 (0.93) 0.000
Mental Health 7.6 (1.9) 0.83 (1.83) 0.42 (1.98) 0.37 (1.81) 0.82 (1.78) 0.91 (1.78) 1.10 (1.82) 0.000weight loss as part of its tailored interventions in the management of
knee and hip OA. This program was conducted with the aim of a 7-10%
loss of body weight by dietary intervention over 18 weeks. The partic-
ipants were provided online and written healthy eating advice and
lifestyle education and tools together with targeted telephone moti-
vation and support. The dietary habits were changed over 3 phases:
phase 1 - motivational weight loss utilizing low calorie diet meal
replacement, with controlled portions, and free foods for 6 weeks;
phase 2 - consolidationweight loss for 6 weeks and phase 3 -short term
weight maintenance. All participants in this cohort received the same
strength / balance / mobility exercise tools, instruction, support and
encouragement. All participants were assessed at baseline, 6 weeks and
18 weeks for body weight and non-disease speciﬁc measure of quality
of life, assessed by SF-12 instrument. The SF-12measures general health
status from the patient's point of view. It includes 8 concepts commonly
represented in health surveys: physical functioning, role functioning
physical, bodily pain, general health, vitality, social functioning, role
functioning emotional, and mental health. Results are expressed in
terms of two meta-scores: the Physical Component Summary (PCS) and
theMental Component Summary (MCS). The PCS andMCS scores have a
range of 0 to 100 and have a mean score of 50 and a standard deviation
(SD) of 10 in a healthy US population. Thus, scores greater than 50
represent above average health status. The dose-response relationships
between ﬁveweight-change categories (10%weight loss, 9.9-7.5%, 7.4-
5%, 5-2.4% and <2.5%) and change in SF-12 scores were assessed using
repeated measures ANCOVA and controlled for baseline BMI and
gender.
Results: 2175 (71% females) persons were enrolled in this study. Mean
age, height and weight was 64 years (SD ± 8.6), 1.66m (SD ± 0.09) and
95.3 (SD ± 17.4) respectively. The mean body mass index (BMI) was 34.4
(SD ± 5.2) with 81.7% of participants being obese at baseline. 2002 (92%)of participants had a >2.5% reduction in body weight. 1832 (84.4%)
participants completed the ﬁnal SF-12 questionnaires and were inclu-
ded in the analyses. The number (%) of participants according to per-
centage weight loss categories were as follows: less than 2.5% ¼ 156
(7.2%), 2.5-4.9% ¼ 353(16.2%), 5-7.4% ¼ 543 (25.0%), 7.5-9.9% ¼ 481
(22.1%) more than 10% ¼ 636 (29.2%). There were no signiﬁcant dif-
ferences between weight loss categories for gender, age or baseline SF-
12 measures. There were signiﬁcant changes in all 8 subdomains of SF-
12 quality of life measures between initial and ﬁnal assessments. Both
Physical Health Composite Score (PCS) and Mental Health Composite
Score (MCS) were strongly associated with weight loss. There was sig-
niﬁcant dose-response relationship between changes in SF-12 quality of
life measures both composite (PCS and MCS) and individual sub-
domains (physical functioning, role functioning physical, bodily pain,
general health, vitality, social functioning, role functioning emotional,
and mental health) across weight loss categories (Table1).
Conclusions: There is a strong dose-response relationship between
weight loss and the improvement in quality of life assessed by using SF-
12 health questionnaires. This study conﬁrms the beneﬁt of weight loss
as a therapeutic intervention in knee osteoarthritis not only as
improving the OA symptoms but also increasing the quality of life of OA
sufferers.642
ANALYSIS OF ANTHROPOMETRIC MEASUREMENTS AND DIETARY
INTAKE IN PATIENTS UNDERGOING A MULTI-PROFESSIONAL
PROGRAM OSTEOARTHRITIS TREATMENT (PARQVE e PROJECT
ARHTRITIS RECOVERING QUALITY OF LIFE BY MEANS OF
EDUCATION)
N.L. Brito, Sr., M.U. Rezende, G.C. Campos, M.I. Hissadomi, T. Pasqualim,
A.F. Pailo, R. Fruchi, O.P. Camargo. Inst. de Ortopedia e Traumatologia e
HC FMUSP, S~ao Paulo, Brazil
Purpose: To evaluate the effect of the care and educational multi-pro-
fessional treatment in patients with knee osteoarthritis (KOA) by
anthropometric measurements, variation of percentage of body fat, and
questionnaires and correlate results obtained.
Methods:One hundred and ninety-eight patients in usual treatment for
KOA were randomized to 4 groups. All groups received a booklet and a
DVD with information regarding KOA (causes and treatment modal-
ities). Three groups (1,2 and 3) also attended two days of lectures 1,2
and 3 months apart, respectively. All groups were divided in subgroups
A (bimonthly telephone calls) and B (no telephone calls). All patients
were evaluated at baseline and at one year with height, weight (BMI
estimation), waist and hip circumference (waist-hip ratio), percentage
of body fat, through the measurement of seven skinfolds, calorie intake,
from 24 hours recording, and asked to answerWOMAC, LEQUESNE, VAS
and SF-36 questionnaires.
Results: The waist-hip ratio showed a predominance of android obesity
at baseline (89.4% of androids and 10.6% of ginecoids) and at one year
(87.9% and 12.1% respectively) with no signiﬁcant improvement
(p¼0.38). The average percentage of body fat decreased 0.44 from
baseline to 12months, regardless of group or telephone calls. Telephone
calls determined average lower calorie intake at 12 months on group 1
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average lower calorie intake than the groups 2A (-781.8, CI -1472.7,
-91.0, p¼0.008) and 3A (-885.8, CI -1599.3, -172.2, p¼ 0.001). Therewas
no correlation between calories intake and waist-hip ratio at baseline
and reassessment with any of the questionnaires. BMI and percentage
of body fat correlated with WOMAC, WOMAC pain, VAS and Lequesne
scores at baseline and at reassessment. Only changes in BMI correlated
weakly with one-year results of the WOMAC (r¼-0.172, p¼0.016),
WOMAC pain (r¼-0.193, p¼0.007), LEQUESNE (r¼-0.197, p¼0.006) and
SF-36-MCS (r¼0.160, p¼0.027); and with changes in WOMAC (r¼0.220,
p¼0.002), WOMAC pain (r¼0.199, p¼0.006), VAS (r¼0.170, p¼0.018).
Changes in porcentage of body fat did not correlate with any of the pain,
function and quality of life changes.
Conclusions: Themulti-professional treatment improved percentage of
body fat at one year. This improvement does not correlate with classes,
telephone calls or improvements in pain, function and quality of life
questionnaires (WOMAC, WOMAC pain, VAS, LEQUESNE and SF-36).
Calorie intake improved and was inﬂuenced by telephone calls and
classes one month apart, and does not correlate with changes in pain,
function and quality of life. Changes in BMI correlated with changes in
pain and function but not with quality of life.
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THE EFFECTIVENESS OF MANUAL THERAPY FOR RELIEVING PAIN,
STIFFNESS AND DYSFUNCTION IN KNEE OSTEOARTHRITIS: A
SYSTEMATIC REVIEW AND META-ANALYSIS
Q. Xu y, J. Pang y, Y. Zheng y, H. Zhan y, Y. Cao y,z, C. Ding z. y Shi’s Ctr. of
Orthopedics and Traumatology, Shuguang Hosp. Afﬁliated to Shanghai
Univ. of Traditional Chinese Med., Shanghai, China; zMenzies Inst. for
Med. Res., Univ. of Tasmania, Hobart, Australia
Purpose: Manual therapy, including massage, joint mobilization,
manipulation, and Chinese tuina, is one of non-pharmacologic meas-
ures mostly used for musculoskeletal conditions. Our aim was to
determine the effectiveness of manual therapy for the treatment of
symptomatic knee OA.Methods:We have searched 7 Chinese and English databases including
PubMed, EMBASE, Cochrane Library, China Knowledge Resource Inte-
grated Database (CNKI), Weipu Database for Chinese Technical Peri-
odicals (VIP), andWanfang Data from inception to October of 2014, used
all the possible Medical Subject Heading (MeSH) and keywords. We
included human RCTs of manual therapy for knee OA with the assess-
ment of WOMAC for outcomes. Study quality was evaluated with PEDro
scale. Pooled data was expressed as standard mean difference (SMD)
with 95% conﬁdent intervals (CI) using a random effects model. The
meta-analyses of manual therapy for knee OA on pain, stiffness, physical
function and total score were conducted respectively.
Results: 1171 potential relevant studies were identiﬁed. 14 studies (5 in
English and 9 in Chinese), with 841participants met our inclusion cri-
teria. Mean age was 61.4 years, mean treatment durationwas 5.8 weeks
(range 2 to 12 weeks), sample size ranged from 36 to 120 (total 841,
233males and 608 females). The overall study quality was modest
(mean PEDro score ¼ 6.6). The results of meta-analysis suggested that
manual therapy had statistically signiﬁcant effects on relieving pain
(SMD ¼ -0.61, 95% CI -0.95 to -0.28, I2 ¼ 76%), stiffness (SMD ¼ -0.58,
95% CI -0.95 to -0.21, I2 ¼ 81%), improving physical function (SMD ¼
-0.49, 95% CI -0.76 to -0.22, I2¼ 65%), and total score (SMD ¼ -0.56, 95%
CI -0.78 to -0.35, I2¼ 50%)(Figure 1).In contrast, therewas no signiﬁcant
improvement on stiffness and physical function when treatment
duration was less than 4 weeks.
Conclusions: The preliminary evidence suggests that manual therapy
maybe effective in the treatment of knee OA. Rigorous and well-con-
trolled larger-scale RCTs with long-term follow-up are warranted to
conﬁrm our ﬁndings.
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REDUCTION OF KNEE OSTEOARTHRITIS SYMPTOMS IN A COHORT OF
BARIATRIC SURGERY PATIENTS
E. Wilder y, A. Leyton-Mange y, J. Lin y, M. Parikh z, C. Ren-Fielding z,
r. La Rocca Vieira y, S.B. Abramson y, J. Samuels y. yNYU Langone Hosp.
for Joint Diseases, New York, NY, USA; zNYU Langone Med. Ctr., New
York, NY, USA
Purpose: Obesity is amodiﬁable risk factor of knee osteoarthritis (KOA).
While diet, exercise and other conservative treatments can have limited
and often transient beneﬁcial effects, an alternative strategy would
target weight loss via surgery to delay or avoid joint replacement. Some
retrospective data, including a study from our group, have in fact shown
sustained improvement in KOA pain after bariatric surgery. We initiated
a prospective study to evaluate painful KOA in the obese population,
and track whether weight loss after bariatric surgery affects KOA-rela-
ted pain and physical function.
Methods: We screened consecutive patients prior to laparoscopic
adjustable gastric banding (LAGB), sleeve gastrectomy, or gastric bypass
(RYGB), at NYU Langone Medical Center and Bellevue Hospital Center.
Patients age 21 with knee pain for 1 month and a visual analog scale
pain score 30mm were enrolled, excluding those with lupus, rheu-
matoid arthritis, psoriatic arthritis, or psoriasis. Baseline pre-op
assessments included x-rays for OA severity by Kellgren-Lawrence (KL)
grade, the Knee Injury and Osteoarthritis Outcome Score (KOOS), and
the Western Ontario McMasters Universities Osteoarthritis Index
(WOMAC) with a Likert scale calculated from the KOOS. Patients were
consented for optional tissue collection (blood, urine and intra-oper-
ative adipose samples) for future biomarker analysis. They are (still)
completing the questionnaires and being measured for BMI and %
excess weight loss (%EWL) at 1,3,6 and 12 month post-op intervals.
Results: In total, we screened 537 patients planning to have bariatric
surgery, found that 309 (58%) of them reported knee pain e and
enrolled 176whomet criteria and consented for the study. Our cohort is
89.7% female, with a mean BMI of 43.6 kg/m2±7 (31.6-60.6), a mean age
of 42.4 ±11 (18-73), and radiographic severity as follows: KL0¼43 (25%),
KL1¼34 (19%), KL2¼38 (22%), KL3¼34 (19%), KL4¼27 (15%). The mean
pre-op KOOS scores were 45.4 for pain and 46.0 for ADL (0¼worst,
100¼best), the mean pre-op WOMAC pain score (Likert scale) was 11
(0¼best, 20¼worst), and the mean overall WOMAC index was 52
(0¼best, 96¼worst). Before surgery, a higher KL correlated with
symptoms; mean KOOS painwas 53.2, 48.1 and 36.7 for KL0, KL1-2, and
KL3-4 (p¼0.00002 for KL0 vs KL3-4, and p¼0.0005 for KL1-2 vs KL3-4),
with similar trends across other KOOS and WOMAC scores. Higher BMI
also trended with worse pre-op knee symptoms, as the tertiles with the
lowest and highest BMIs (31-39 and 46-61) had mean KOOS pain scores
